The rapidly declining prevalence of Helicobacter pylori infection and widespread use of
potent anti-secretory drugs means peptic ulcer disease has become substantially less …

The treatment of chronic illnesses commonly includes the long-term use of
pharmacotherapy. Although these medications are effective in combating disease, their full …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …

Background Dual antiplatelet therapy (DAPT) cessation increases the risk of adverse events
after percutaneous coronary intervention (PCI). Whether risk changes over time, depends on …

Background: The optimal duration of dual antiplatelet therapy (DAPT) following second-
generation drug-eluting stent (DES) implantation is still debated. Objectives: The aim of this …

Background The relative safety of drug-eluting stents and bare-metal stents, especially with
respect to stent thrombosis, continues to be debated. In view of the overall low frequency of …

Background—The optimal duration of dual-antiplatelet therapy and the risk-benefit ratio for
long-term dual-antiplatelet therapy after coronary stenting remain poorly defined. We …

Background—The optimal duration of dual antiplatelet therapy (DAPT) after implantation of
drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month …

Background Previous studies have established the superiority of coronary everolimus-
eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However …